Patents by Inventor Kyung Jung

Kyung Jung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240270713
    Abstract: The present invention relates to a novel compound exhibiting anti-inflammatory activity, and the compound of the present invention plays a critical role in the generation of pro-inflammatory cytokines, thereby having excellent inhibitory activity against p38 MAPK, which is known to cause inflammatory diseases, and thus can be effectively used as an agent for treating inflammatory diseases.
    Type: Application
    Filed: December 23, 2021
    Publication date: August 15, 2024
    Applicant: PRAZERTHERAPEUTICS INC.
    Inventors: Kyung-Soo Inn, Nam-Jung Kim, Jong Kil Lee, Ga Yeong Kim, Kyeojin Kim, Donghwan Kim, Jimin Do, Chaewon Song, Na-Rae Lee
  • Publication number: 20240266859
    Abstract: A battery management apparatus according to an embodiment of the present disclosure includes a profile obtaining unit configured to obtain a gas amount profile indicating a correspondence relationship between a gas generation amount of a battery and a change amount of a peak; a profile generating unit configured to generate a differential profile for a battery profile indicating a correspondence relationship between a capacity of the battery and a differential voltage; and a control unit configured to determine a change amount of a target peak in the battery profile received from the profile generating unit and set a usage condition of the battery based on a result determined by comparing the determined change amount of the target peak with a control criterion of the gas amount profile.
    Type: Application
    Filed: June 2, 2023
    Publication date: August 8, 2024
    Inventors: Ji-Yeon KIM, Kyung-Hwa WOO, Yoon-Jung BAE
  • Patent number: 12057271
    Abstract: A multilayer electronic component includes a body including a dielectric layer and an internal electrode alternately disposed with the dielectric layer interposed therebetween in a first direction; and an external electrode disposed on the body and connected to the internal electrode, wherein 0.46 to 1.08 at % is a range of an indium (In) content compared to nickel (Ni) and indium (In) contents in a surface layer portion of the internal electrode.
    Type: Grant
    Filed: June 15, 2022
    Date of Patent: August 6, 2024
    Assignee: SAMSUNG ELECTRO-MECHANICS CO., LTD.
    Inventors: Yu Hong Oh, Jun Oh Kim, Byung Kun Kim, Min Jung Cho, Won Mi Choi, Su Yeon Lee, Kyung Ryul Lee, Yun Sung Kang
  • Publication number: 20240255512
    Abstract: The present disclosure relates to a biomarker for diagnosis of oral cancer, using metabolite profiling and, more specifically, to a biomarker composition containing an acyl carnitine metabolite which varies in quantity upon the onset of oral cancer, and a diagnostic method for oral cancer, using same. The present disclosure allows for the early diagnosis of oral cancer which has been conventionally difficult to diagnose due to the impossible tissue biopsy thereof, and can reduce the pain and risk burden of patients because it uses a liquid biopsy method in which a blood sample is collected and analyzed.
    Type: Application
    Filed: May 31, 2022
    Publication date: August 1, 2024
    Applicants: NATIONAL CANCER CENTER, KOREA BASIC SCIENCE INSTITUTE
    Inventors: Mi Kyung KIM, Sung Weon CHOI, Geum Sook HWANG, Young Ae JUNG
  • Publication number: 20240255823
    Abstract: An infrared adaptive transparent camouflage film includes a substrate, a graphene layer, an electrode layer and an ion gel layer. The substrate has dielectric. The graphene layer is disposed on the substrate and stacked in multiple layer. The electrode layer is disposed over the substrate and is spaced apart from the graphene layer. The ion gel layer is disposed over the graphene layer and the electrode layer, or disposed between the graphene layer and the electrode layer, to dope the graphene layer electrically.
    Type: Application
    Filed: May 3, 2022
    Publication date: August 1, 2024
    Inventors: Mi Kyung LIM, Hyeon Don KIM, Kwang Seop KIM, Jae Hyun KIM, Hyun June JUNG, Hak Joo LEE, Seung Min HYUN
  • Publication number: 20240246940
    Abstract: The present invention relates to a heteroaryl derivative compound and a use thereof. The heteroaryl derivative of the present invention exhibits excellent inhibitory activity against HER2 and EGFR, and thus can be effectively used as a therapeutic agent for HER2- and/or EGFR-associated diseases.
    Type: Application
    Filed: April 8, 2022
    Publication date: July 25, 2024
    Inventors: Yi Kyung KO, Jin Hee PARK, Yeong Deok LEE, Hye Rim IM, Kyun Eun KIM, Dong Keun HWANG, Ah Reum HAN, Su Been NAM, Myung Hoe HEO, Eun Hwa KO, Hwan Geun CHOI, Sung Hwan KIM, Hong Ryul JUNG, Ji Hye YOO
  • Publication number: 20240248090
    Abstract: The present invention relates to an epitope of a thioredoxin-1 (Trx1) antigen and a use thereof, and more particularly, to the epitope, and an antibody or an antigen-binding fragment binding thereto. The epitope region of the human Trx1 antigen confirmed in the present invention may be effectively used in the development of an improved antibody to enhance the binding affinity of an anti-Trx1 antibody. In addition, the improved antibody of the present invention is effective in improvement of performance of a breast cancer diagnosis kit due to excellent binding affinity for Trx1 and very high sensitivity and specificity, compared to a conventional anti-Trx1 antibody. Further, the accuracy and reliability of breast cancer diagnosis may significantly increase because exceptionally high sensitivity and specificity are exhibited by detecting the monoclonal antibody of the present invention, which specifically binds to Trx1, rather than detecting CA15-3, another conventional breast cancer diagnostic biomarker.
    Type: Application
    Filed: February 16, 2024
    Publication date: July 25, 2024
    Applicant: E&S HEALTHCARE CO., LTD.
    Inventors: Kyong Hoon SUH, Dae Joong KIM, Young KIM, Mi Kyung KIM, Jong Hwan JUNG, Ki Se LEE
  • Patent number: 12037338
    Abstract: The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same: wherein X, Z, R1 and R2 are as defined in the specification. The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.
    Type: Grant
    Filed: June 1, 2021
    Date of Patent: July 16, 2024
    Assignee: SK BIOPHARMACEUTICALS CO., LTD.
    Inventors: Chun Eung Park, Young Koo Jang, Yong Je Shin, Ji Yeon Kim, Seung Mo Ham, Yong Gil Kim, Hye Kyung Min, Soo Bong Cha, Hyo Jun Jung, Ju Young Lee, Seung Nam Han, Jin Yong Chung, Eun Ju Choi, Chan Mi Joung, Jong Sil Park, Ji Won Lee, Nahm Ryune Cho, Eun Ju Ryu, Cheol Young Maeng
  • Publication number: 20240228946
    Abstract: Provided are a recombinant microorganisms having a genetic modification that increases the expression of bacterioferritin, a composition comprising the recombinant microorganism for use in reducing a nitrogen oxide concentration in a sample, and a method of reducing a nitrogen oxide concentration in a sample.
    Type: Application
    Filed: April 17, 2023
    Publication date: July 11, 2024
    Inventors: Yu Kyung Jung, Jae-Young Kim, Seung Hoon Song, Woo Yong Shim
  • Publication number: 20240233123
    Abstract: A computing device includes at least one memory, and at least one processor configured to generate, based on first analysis on a pathological slide image, first biomarker expression information, generate, based on a user input for updating at least some of results of the first analysis, second biomarker expression information about the pathological slide image, and control a display device to output a report including medical information about at least some regions included in the pathological slide image, based on at least one of the first biomarker expression information or the second biomarker expression information.
    Type: Application
    Filed: March 20, 2024
    Publication date: July 11, 2024
    Applicant: LUNIT INC.
    Inventors: Jeong Seok KANG, Dong Geun YOO, Soo Ick CHO, Won Kyung JUNG
  • Patent number: 12024710
    Abstract: A recombinant microorganism of the genus Escherichia, comprises a genetic modification that increases expression of a nosZ gene encoding NosZ, which is a nitrous oxide reductase, in the recombinant microorganism, wherein the recombinant microorganism comprises a nosR gene encoding NosR, a nosD gene encoding NosD, a nosF gene encoding NosF, a nosY gene encoding NosY, and an apbE gene encoding ApbE, and wherein the nosR gene, the nosD gene, the nosF gene, the nosY gene and the apbE gene are derived from a microorganism of the genus Pseudomonas, the genus Paracoccus, or a combination thereof.
    Type: Grant
    Filed: May 26, 2021
    Date of Patent: July 2, 2024
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Woo Yong Shim, Seung Hoon Song, Jae-Young Kim, Dongsik Yang, Yu Kyung Jung
  • Publication number: 20240214654
    Abstract: One embodiment of a camera module may comprise: a lens barrel; a heater arranged at the rear of the lens barrel; a connection unit, which has the heater mounted therein, is coupled to the lens barrel so as to be in close contact with the heater and is electrically connected to the heater; and a printed circuit board, which is accommodated in the connection unit, is electrically connected to the heater through the connection unit and has an image sensor mounted therein.
    Type: Application
    Filed: April 28, 2022
    Publication date: June 27, 2024
    Inventors: Mean-Seok GU, Hee-Joong LEE, Kyung-Jung KIM, Jong-Ryul KIM, Ki-Kang KIM
  • Publication number: 20240183679
    Abstract: A vehicle control device includes: an input unit configured to receive provision order information, such as food and/or beverage order information, from a terminal of a vehicle passenger or a vehicle user interface; a search unit configured to search for at least one vehicle control command matched with the provision order information; and a controller configured to output the vehicle control command for a predetermined time based on a provision reception time according to the provision order information and control an output of a corresponding vehicle component.
    Type: Application
    Filed: July 13, 2023
    Publication date: June 6, 2024
    Applicant: HYUNDAI MOBIS CO., LTD.
    Inventor: Soo Kyung JUNG
  • Publication number: 20240155953
    Abstract: A semiconductor device may include a first pattern including any one of a selector layer or a variable resistance layer and a middle electrode layer disposed over any one of the selector layer or the variable resistance layer; and a second pattern disposed over the first pattern and including the other one of the selector layer or the variable resistance layer, wherein a width of the second pattern may be the same as or greater than a width of the first pattern.
    Type: Application
    Filed: June 8, 2023
    Publication date: May 9, 2024
    Inventors: Cha Deok DONG, Guk Cheon KIM, Bo Kyung JUNG, Keo Rock CHOI, Kenichi YOSHINO, Kazuya SAWADA, Naoki AKIYAMA, Takuya SHIMANO
  • Patent number: 11978594
    Abstract: A multilayer ceramic electronic component includes a ceramic body, and first and second external electrodes disposed on the surface of the ceramic body, respectively. The ceramic body includes a capacitance forming portion including a dielectric layer and internal electrodes, margin portions disposed on both sides of the capacitance forming portion, and cover portions disposed on both sides of the capacitance forming portion. The first and second external electrodes include first and second base electrodes, respectively, first and second conductive layers disposed on edges of the first and second base electrodes, respectively, and first and second terminal electrodes covering the first and second base electrodes, respectively.
    Type: Grant
    Filed: April 17, 2023
    Date of Patent: May 7, 2024
    Assignee: SAMSUNG ELECTRO-MECHANICS CO., LTD.
    Inventors: In Kyung Jung, Dong Hwi Shin
  • Publication number: 20240132834
    Abstract: Provided are a recombinant microorganisms having a genetic modification that increases the expression of bacterioferritin, a composition comprising the recombinant microorganism for use in reducing a nitrogen oxide concentration in a sample, and a method of reducing a nitrogen oxide concentration in a sample.
    Type: Application
    Filed: April 16, 2023
    Publication date: April 25, 2024
    Inventors: Yu Kyung Jung, Jae-Young Kim, Seung Hoon Song, Woo Yong Shim
  • Patent number: 11967076
    Abstract: A computing device includes at least one memory, and at least one processor configured to generate, based on first analysis on a pathological slide image, first biomarker expression information, generate, based on a user input for updating at least some of results of the first analysis, second biomarker expression information about the pathological slide image, and control a display device to output a report including medical information about at least some regions included in the pathological slide image, based on at least one of the first biomarker expression information or the second biomarker expression information.
    Type: Grant
    Filed: March 17, 2023
    Date of Patent: April 23, 2024
    Assignee: LUNIT INC.
    Inventors: Jeong Seok Kang, Dong Geun Yoo, Soo Ick Cho, Won Kyung Jung
  • Publication number: 20240119930
    Abstract: Disclosed are an artificial intelligence device and a method for operating the same. An artificial intelligence device according to at least one embodiment of various embodiments of the present disclosure includes: a display; and a processor configured to control the display, wherein the processor is configured to: receive and register a first wake-up word; activate a voice recognition function when the registered first wake-up word is received, and transmit the first wake-up word to a server, wherein the first wake-up word is not a basic wake-up word embedded in the artificial intelligence device.
    Type: Application
    Filed: June 19, 2023
    Publication date: April 11, 2024
    Applicant: LG ELECTRONICS INC.
    Inventors: Eun Kyung JUNG, Sung Eun KIM
  • Publication number: 20240102054
    Abstract: A method of reducing a concentration of a nitrogen oxide, the method comprising: contacting a microorganism with a nitrogen oxide-containing sample to reduce the concentration of the nitrogen oxide in the sample, wherein the contacting comprises contacting the microorganism with Fe(II)(L)-NOx in a bioreactor, wherein the Fe(II)(L)-NOx is a complex in which a chelating agent, Fe2+, and NOx are chelated, wherein L is the chelating agent, and wherein NOx is a nitrogen oxide ligand.
    Type: Application
    Filed: September 21, 2023
    Publication date: March 28, 2024
    Inventors: Seung Hoon Song, Heejoo Han, Woo Yong Shim, Sukhwan Yoon, Jae-Young Kim, Sojung Yoon, Yu Kyung Jung
  • Publication number: 20240091355
    Abstract: The present invention relates to a composition, for prevention or treatment of cancer diseases, comprising CD8+ T cells activated by CD4+ T cell-derived extracellular vesicles as an active ingredient. It was found that the secretion of extracellular vesicles from cytokine-activated CD4+ T cells increases and the extracellular vesicles enhance proliferation and activity of CD8+ T cells to induce the death of cancer cells, thereby augmenting an anticancer effect. Thus, the present invention provides the CD8+ T cells activated by CD4+ T cell-derived extracellular vesicles as a pharmaceutical agent or an immunotherapeutic agent for cancer diseases, and a method for activating CD8+ T cells by using CD4+ T cell-derived extracellular vesicles to prepare CD8+ T cells showing excellent anticancer activity as described above.
    Type: Application
    Filed: September 18, 2020
    Publication date: March 21, 2024
    Applicants: KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Moon-Chang BAEK, Kyungmoo YEA, Do Kyung JUNG, Suyeon RYU, Sang Hee SHIN, In Seong JUNG